QHSLab, Inc.
USAQ · OTCMCIK 856984fmd_1V8PKBY36PRNWJPV1SWFCVCWY6Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2026, 66 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | 0 | 1 | 1 | 1 | 2 | 3 |
| Cost of revenue | – | – | – | – | 0 | 1 | 1 | 1 | 1 | 1 |
| Gross profit | – | – | – | – | 0 | 1 | 1 | 1 | 1 | 2 |
| Research and development | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, general and administrative | – | – | – | – | 0 | 1 | 1 | 1 | 1 | 1 |
| Total operating expenses | – | – | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 |
| Operating income | (0) | (0) | (0) | (0) | (0) | (1) | (1) | (0) | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before taxes | – | – | – | – | (0) | (1) | (1) | (0) | (0) | 0 |
| Income tax expense | – | – | – | – | – | – | 0 | – | – | – |
| Net income from continuing operations | – | – | – | – | – | – | (1) | – | – | – |
| Net income | (0) | (0) | (0) | (0) | (0) | (1) | (1) | (0) | (0) | 0 |
| Net income to common shareholders | – | – | – | – | – | – | – | – | – | – |